Stimulation of myofibrillar protein degradation and expression of mRNA encoding the ubiquitin-proteasome system in C2C12 myotubes by dexamethasone: Effect of the proteasome inhibitor MG-132

Journal of Cellular Physiology

Volumn 181, Issue 3, 1999, Pages 455-461

  Thompson, Michael G ^a   Thom, Amanda ^a   Partridge, Kris ^b   Garden, Karen ^a   Campbell, Gillian P ^a   Calder, Graham ^a   Palmer, Robert M ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; MESSENGER RNA; MUSCLE PROTEIN; PROTEASOME; PROTEASOME INHIBITOR; UBIQUITIN;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; MYOTUBE; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

ADENOSINE TRIPHOSPHATE; ANIMALS; CELLS, CULTURED; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; DEXAMETHASONE; GENE EXPRESSION; LEUPEPTINS; MULTIENZYME COMPLEXES; MUSCLE PROTEINS; MUSCLE, SKELETAL; MYOFIBRILS; PROTEASOME ENDOPEPTIDASE COMPLEX; RATS; RNA, MESSENGER; UBIQUITINS;

EID: 0032694911     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199912)181:3<455::AID-JCP9>3.0.CO;2-K     Document Type: Article

References (41)

1. Auclair D, Garrel DR, Zerouala AC, Ferland LH. 1997. Activation of the ubiquitin pathway in rat skeletal muscle by catabolic doses of glucocorticoids. Am J Physiol 272:C1007-1016.
2. Bird JWC, Carter JH, Triemer RE, Brooks RM, Spanier AM. 1980. Proteinases in cardiac and skeletal muscle. Fed Proc Fed Am Soc Exp Biol 39:20-25.
3. Cato ACB, Wade E. 1996. Molecular mechanisms of antiinflammatory action of glucocorticoids. BioEssays 18:371-378.
4. Ciechanover A. 1994. The ubiquitin-proteasome proteolytic pathway. Cell 79:13-21.
5. Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
6. Curran T, Franza BR Jr. 1988. Fos and Jun: the AP-1 connection. Cell 55:395-397.
7. Dayton WR, Goll DE, Reece MG, Robson RM, Reville WJ. 1976. A calcium-activated protease possibly involved in myofibrillar protein turnover: purification from porcine muscle. Biochemistry 15:2150-2158.
8. Fagan JM, Waxman L, Goldberg AL. 1987. Skeletal muscle and liver contain a soluble ATP 1 ubiquitin-dependent proteolytic system. Biochem J 243:335-343.
9. Goldberg AL. 1992. The mechanisms and functions of ATP-dependent proteases in bacterial and animal cells. Eur J Biochem 203:9-23.
10. Goodman MN. 1987. Acute alterations in sodium flux in vitro lead to decreased myofibrillar protein breakdown in rat skeletal muscle. Biochem J 247:151-156.
11. Hall-Angeras M, Angeras U, Hasselgren PO, Fischer JE. 1990. Corticosterone alone does not explain increased muscle proteolysis in septic rats. J Surg Res 48:368-372.
12. Hasselgren PO, Zamir O, James JH, Fischer JE. 1990. Prostaglandin E2 does not regulate total or myofibrillar protein breakdown in incubated skeletal muscle from normal or septic rats. Biochem J 270:45-50.
13. Haverberg LN, Deckelbaum L, Bilmazes C, Munro HN, Young VR. 1975. Myofibrillar protein turnover and urinary Nt-methylhistidine output. Response to dietary supply of protein and energy. Biochem J 152:503-510.
14. Jonat C, Rahmsdorf HJ, Park KK, Cato ACB, Gebel S, Ponta H, Herrlich P. 1990. Antitumor promotion and antiinflammation: down modulation of AP-1 (fos/jun) activity by glucocorticoid hormone. Cell 62:1189-1204.
15. Kayali AG, Young VR, Goodman MN. 1987. Sensitivity of myofibrillar proteins to glucocorticoid induced muscle proteolysis. Am J Physiol 252:E621-626.
16. Kayali AG, Goodman MN, Lin J, Young R. 1990. Insulin-and thyroid hormone-independent adaptation of myofibrillar proteolysis to glucocorticoids. Am J Physiol 259:E699-705.
17. Kettelhut IC, Wing SS, Goldberg AL. 1988. Endocrine regulation of protein breakdown in skeletal muscle. Diabetes Metab Rev 8:751-772.
18. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275.
19. Medina R, Wing SS, Goldberg AL. 1995. Increase in levels of polyubiquitin and proteasome mRNA in skeletal muscle during starvation and denervation atrophy. Biochem J 307:631-637.
20. Millward DJ, Bates PC. 1983. 3-methyhistidine turnover in the whole body, and the contributions of skeletal-muscle and intestine to urinary 3-methylhistidine excretion in the adult rat. Biochem J 214:605-615.
21. 12 myotubes in association with the activation of 26S proteasome. Biochem Biophys Res Commun 228:813-818.
22. Odedra BR, Bates PC, Millward DJ. 1983. Time course of the effect of catabolic doses of corticosterone on protein turnover in rat skeletal muscle and liver. Biochem J 214:617-627.
23. Palmer RM, Bain PA. 1989. Indomethacin inhibits the insulin-induced increases in RNA and protein synthesis in L6 skeletal muscle myoblasts. Prostaglandins 37:193-203.
24. Palmer RM, Thompson MG. 1999. Potential intracellular targets for anabolic/anti-catabolic therapies. Curr Opin Clin Nutr Metab Care 2:213-218.
25. Peters JM. 1994. Proteasomes: protein degradation machines of the cell. Trends Biochem Sci 19:377-382.
26. Price SR, England BK, Bailey JL, Vreede KV, Mitch WE. 1994. Acidosis and glucocorticoids concomitantly increase ubiquitin and proteasome subunit mRNAs in rat muscle. Am J Physiol 267:C955-960.
27. Rock KL, Gramm C, Rothstein L, Clark K, Stein R, Dick L, Hwang D, Goldberg AL. 1994. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class 1 molecules. Cell 78:761-771.
28. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning. A Laboratory Manual. Cold Spring Harbor Laboratory Press, New York.
29. Santidrian S, Moreyra M, Munro HM, Young VR. 1981. Effect of corticosterone and its route of administration on muscle protein breakdown, measured in vivo by urinary excretion of Nt-methylhistidine in rats: response to different levels of dietary protein and energy. Metab Clin Exp 30:798-804.
30. Schule R, Rangarajan P, Kliewer S, Ransone LJ, Bolado J, Yang N, Verma IM, Evans RM. 1990. Functional antagonism between oncoprotein c-jun and the glucocorticoid receptor. Cell 62:1217-1226.
31. Solomon V, Goldberg AL. 1996. Importance of the ATP-ubiquitinproteasome pathway in the degradation of soluble and myofibrillar proteins in rabbit muscle extracts. J Biol Chem 271:26690-26697.
32. Thompson MG, Palmer RM, Thom A, Garden K, Lobley GE, Calder G. 1996. Metabolic and pharmacological effects on Nt-methylhistidine turnover in skeletal muscle cells measured by GC-MS. Am J Physiol 270:C1875-1879.
33. Thompson MG, Mackie SC, Thom A, Palmer RM. 1997. Regulation of phospholipase D in L6 skeletal muscle myoblasts. J Biol Chem 272:10910-10916.
34. Thompson MG, Palmer RM. 1998. Signalling pathways regulating protein turnover in skeletal muscle. Cell Signal 10:1-11.
35. Tomas FM, Munro HN, Young VR. 1979. Effect of glucocorticoid administration on the rate of muscle protein breakdown in vivo in rats, as measured by urinary excretion of Nt-methylhistidine. Biochem J 178:139-146.
36. Wassner SJ, Li JB. 1982. Nt-methylhistidine release: contributions of rat skeletal muscle, GI tract, and skin. Am J Physiol 243:E293-297.
37. Wing SS, Goldberg AL. 1993. Glucocorticoids activate the ATP-ubiquitin-dependent proteolytic system in skeletal muscle during fasting. Am J Physiol 264:E668-676.
38. Wing SS, Banville D. 1994. 14-kDa ubiquitin-conjugating enzyme: structure of the rat gene and regulation upon fasting and by insulin. Am J Physiol 267:E39-E48.
39. Wing SS, Bedard N. 1996. Insulin-like Growth Factor 1 stimulates degradation of an mRNA transcript encoding the 14 KDa ubiquitinconjugating enzyme. Biochem J 319:455-461.
40. Young VR, Alexis SD, Baliga BS, Munro HN. 1972. Metabolism of administered 3-methyhistidine: lack of muscle transfer of ribonucleic acid charging and quantitative excretion of 3-methylhistidine N-acetyl derivative. J Biol Chem 247:3592-3600.
41. Zamir O, Hasselgren PO, von Allmen D, Fischer JE. 1991. The effect of interleukin-1a and the glucocorticoid receptor blocker RU 38486 on total and myofibrillar protein breakdown in skeletal muscle. J Surg Res 50:579-583.